SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonalds shares sold off after management warned that elevated inflation and weak restaurant traffic could persist, while its long-term growth strategy and planned franchisee support raised concerns about spending and near-term returns. Traders debated whether the decline was an overreaction and a buying opportunity or a sign that high prices and softer consumer demand are weighing on the business.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Vikings proposed stock and convertible-note financing is driving debate after encouraging VK2735 obesity-drug maintenance data: critics say the raise could dilute shareholders and disrupt momentum, while supporters argue it funds development and commercialization and strengthens the companys negotiating position. Traders also remain focused on the drugs potential in the competitive obesity market, with short-squeeze speculation amid volatile trading.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAILs Galleri cancer blood test is drawing attention after an FDA advisory panel voted that its benefits outweigh its risks, despite a closer vote on effectiveness; the panels recommendation is not a final FDA approval. Traders are largely treating the outcome as a win, while debating the implications for labeling, coverage and the stocks sharp moves.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Edgewater Researchs warning that AppLovins MAX ad platform may be nearing a growth ceiling, with competition pressuring market-share gains and revenue spreads, is driving the selloff. Traders are divided: some see the note as unconvincing and view the pullback as a buying opportunity, while others are concerned growth may be stalling; Citis reported e-commerce client expansion is cited as a bullish counterpoint.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys first Alloy Kore design win, selected by Coreturaa venture founded by Daimler Truck and Volvo Grouphas drawn attention alongside the upcoming quarterly report; the deal adds a significant estimated royalty backlog and marks QNXs largest design win. Many traders see it as validation of QNXs growth potential, while skeptics question how quickly the backlog will translate into revenue and want the earnings report to demonstrate execution and clear guidance.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unitys strong Q2 results and upbeat outlook, driven by accelerating Vector-powered advertising growth, are fueling attention, alongside analyst upgrades and optimism about the companys turnaround. Traders are bullish on the growth and AI opportunity, though some point to volatility, recent gains, and uncertainty about how much market share Unity is taking from AppLovin.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

GOOGs selloff is being discussed amid rising Treasury yields and expectations for further Fed rate hikes, alongside worries that Google is losing ground to Meta and other rivals in AI and may be spending heavily to compete. Bearish traders see those pressures as reasons for more downside, while some investors view the decline as a buying opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

An FDA alert involving GLP-1 drugs and concerns about regulatory scrutiny of Hims & Hers weight-loss offerings are weighing on sentiment, with traders saying the risks overshadow Australia expansion. The community is divided between concern about compliance and the companys growth prospects in weight loss and peptides; no listed article directly verifies the discussion.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturuss OTC-deficiency Phase 2 update and pipeline announcement, including plans for ARCT-2601 with LUNAR 2.0 and its myNEO acquisition, are driving discussion. Traders see the data and delivery technology as encouraging, while others are concerned about shifted program timelines and the added spending.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets sharp selloff is being linked to rising Treasury yields and renewed rate-hike fears weighing on growth stocks, alongside concern that Metas Muse could intensify competition in AI and search. Traders disagree on whether the move overstates the threat, with bulls citing Googles Gemini and established platform advantages while bears point to growing competitive pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
